SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-305454
Filing Date
2022-12-15
Accepted
2022-12-15 09:30:54
Documents
2
Group Members
BENNY SOFFERCONSONANCE CAPMAN GP LLCCONSONANCE LIFE SCIENCES, LLCKEVIN LIVINGSTONMITCHELL BLUTT

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d408668dsc13da.htm SC 13D/A 106156
2 EX-99.1 d408668dex991.htm EX-99.1 58567
  Complete submission text file 0001193125-22-305454.txt   166597
Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

IRS No.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Subject) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91867 | Film No.: 221463833
SIC: 2836 Biological Products, (No Diagnostic Substances)